Search hospitals > Minnesota > Minneapolis
Minneapolis Heart Institute Foundation
Claim this profileMinneapolis, Minnesota 55407
Global Leader in Heart Failure
Global Leader in Coronary Artery Disease
Conducts research for Heart Attack
Conducts research for Myocardial Infarction or Heart Attack
Conducts research for Myocardial Ischemia
99 reported clinical trials
13 medical researchers
Summary
Minneapolis Heart Institute Foundation is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Heart Failure, Coronary Artery Disease, Heart Attack, Myocardial Infarction or Heart Attack, Myocardial Ischemia and other specialties. Minneapolis Heart Institute Foundation is involved with conducting 99 clinical trials across 144 conditions. There are 13 research doctors associated with this hospital, such as Paul Sorajja, MD, Santiago Garcia, MD, Jay Traverse, MD, and David Lin, Dr..Top PIs
Paul Sorajja, MDAbbott Northwestern Hospital6 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Aortic Valve Stenosis
14 reported clinical trials
24 drugs studied
Santiago Garcia, MDAbbott Northwestern Hospital6 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Aortic Stenosis
13 reported clinical trials
17 drugs studied
Jay Traverse, MDMinneapolis Heart Institute Foundation3 years of reported clinical research
Studies Coronary Artery Disease
Studies Myocardial Ischemia
7 reported clinical trials
7 drugs studied
David Lin, Dr.Minneapolis Heart Institute Foundation1 year of reported clinical research
Studies Atrial Fibrillation
Studies Pericarditis
6 reported clinical trials
5 drugs studied
Clinical Trials running at Minneapolis Heart Institute Foundation
Heart Failure
Tricuspid Regurgitation
Tricuspid Valve Disease
Congestive Heart Failure
Dilated Cardiomyopathy
Patent Foramen Ovale
Myocarditis
Vascular Surgery
Abdominal Surgery
Orthopedic Procedures
Pulmonary Artery Sensor
for Heart Failure
This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordellaâ„¢ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial). The study contains of 5 arms: Randomized Arm - To demonstrate safety and efficacy of the Cordella PA Sensor System in NYHA Class II HF patients. * Treatment Arm (Cohort 1) * Active Control Arm (Cohort 2) * Crossover Arm (Cohort 3) Single Arm - To demonstrate safety and efficacy of the Cordella PA Sensor System linked with a clinician-directed patient self-management strategy in NYHA Class III HF patients. * Clinician-Directed Patient Self-Management Arm (Cohort 4) * Clinician Management Arm (Cohort 5)
Recruiting1 award N/A10 criteria
Virtual Care
for Heart Failure
The purpose of this study is to evaluate how safe and effective a remote, digital intervention is that helps clinicians use and optimally adjust heart failure medications, compared to usual care medication use and adjustment, in participants with heart failure with reduced ejection fraction
Recruiting1 award N/A5 criteria
preCARDIA System
for Heart Failure
Safety and performance evaluation of the preCARDIA System for patients with ADHF.
Recruiting1 award N/A3 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Minneapolis Heart Institute Foundation?
Minneapolis Heart Institute Foundation is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Heart Failure, Coronary Artery Disease, Heart Attack, Myocardial Infarction or Heart Attack, Myocardial Ischemia and other specialties. Minneapolis Heart Institute Foundation is involved with conducting 99 clinical trials across 144 conditions. There are 13 research doctors associated with this hospital, such as Paul Sorajja, MD, Santiago Garcia, MD, Jay Traverse, MD, and David Lin, Dr..